Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth (NYSE:PHR)

[ad_1]

Doctors working on the move

Pekic

Summary

Following my coverage on Phreesia (NYSE:PHR), which I recommended a buy rating as I believe the valuation was attractive after the big share price dip. I thought that the business fundamentals remained sound, and if management were to

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *